BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26472423)

  • 21. Body mass index and survival of patients with lymphoma.
    Chihara D; Larson MC; Robinson DP; Thompson CA; Maurer MJ; Casulo C; Pophali P; Link BK; Habermann TM; Feldman AL; Flowers CR; Cerhan JR; Morton LM
    Leuk Lymphoma; 2021 Nov; 62(11):2671-2678. PubMed ID: 34121594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age.
    Yaqo RT; Jalal SD; Ghafour KJ; Hassan HA; Hughson MD
    J Glob Oncol; 2019 Apr; 5():1-10. PubMed ID: 30978153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
    Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
    Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis.
    Morgensztern D; Walker GR; Koniaris LG; Lossos IS
    Leuk Lymphoma; 2011 Feb; 52(2):194-204. PubMed ID: 21281235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
    Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
    Ann Hematol; 2019 May; 98(5):1169-1176. PubMed ID: 30617643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.
    Yanik EL; Shiels MS; Smith JM; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
    Cancer; 2017 Dec; 123(23):4663-4671. PubMed ID: 28759103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort.
    Desai P; Wallace R; Anderson ML; Howard BV; Ray R; Wu C; Safford M; Martin LW; Schlecht N; Liu S; Cirillo D; Jay A; Manson JE; Simon MS
    Cancer Med; 2018 May; 7(5):2121-2130. PubMed ID: 29608241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupational risk factors for subgroups of non-Hodgkin's lymphoma.
    Tatham L; Tolbert P; Kjeldsberg C
    Epidemiology; 1997 Sep; 8(5):551-8. PubMed ID: 9270958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
    Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
    Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
    Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1074-1078. PubMed ID: 32108027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
    Liu W; Ji X; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Ying Z; Zhang C; Deng L; Wu M; Feng F; Leng X; Sun Y; Du T; Zhu J
    Cancer Med; 2020 Jun; 9(11):3765-3774. PubMed ID: 32281275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
    Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
    Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
    Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
    Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.